Gene · 23521
Papers2,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Vitro Molecular Study of Titanium-Niobium Alloy Biocompatibility. | Biomedicines | 2022 | 36009444 | PubTator, text mining | PubMed |
| CAG Repeat Instability in the Peripheral and Central Nervous System of Transgenic Huntington's Disease Monkeys. | Biomedicines | 2022 | 36009409 | PubTator, text mining | PubMed |
| Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. | Biomedicines | 2022 | 36009355 | PubTator, text mining | PubMed |
| BACH1 Expression Is Promoted by Tank Binding Kinase 1 (TBK1) in Pancreatic Cancer Cells to Increase Iron and Reduce the Expression of E-Cadherin. | Antioxidants (Basel) | 2022 | 36009179 | PubTator, text mining | PubMed |
| The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis. | Front Immunol | 2022 | 36003376 | PubTator, text mining | PubMed |
| FXYD3 facilitates Na+ and liquid absorption across human airway epithelia by increasing the transport capacity of the Na/K ATPase. | Am J Physiol Cell Physiol | 2022 | 35993520 | PubTator, text mining | PubMed |
| Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration, invasion, and self-renewal. | iScience | 2022 | 35992060 | PubTator, text mining | PubMed |
| Genomic targets and selective inhibition of DNA methyltransferase isoforms. | Clin Epigenetics | 2022 | 35987848 | PubTator, text mining | PubMed |
| De novo variants in genes regulating stress granule assembly associate with neurodevelopmental disorders. | Sci Adv | 2022 | 35977029 | PubTator, text mining | PubMed |
| Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native Aβ oligomers to rats. | Acta Neuropathol Commun | 2022 | 35974377 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Cyclobutane Pyrimidine Dimer Hyperhotspots as Sensitive Indicators of Keratinocyte UV Exposure†. | Photochem Photobiol | 2022 | 35944237 | PubTator, text mining | PubMed |
| Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells. | Nat Biomed Eng | 2022 | 35941192 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma. | Front Immunol | 2022 | 35935940 | PubTator, text mining | PubMed |
| Altered muscle oxidative phenotype impairs exercise tolerance but does not improve after exercise training in multiple sclerosis. | J Cachexia Sarcopenia Muscle | 2022 | 35929063 | PubTator, text mining | PubMed |
| Modeling early changes associated with cartilage trauma using human-cell-laden hydrogel cartilage models. | Stem Cell Res Ther | 2022 | 35927702 | PubTator, text mining | PubMed |
| Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer. | Front Oncol | 2022 | 35924161 | PubTator, text mining | PubMed |
| Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia. | Life Sci Alliance | 2022 | 35922154 | PubTator, text mining | PubMed |
| Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo. | Proc Natl Acad Sci U S A | 2022 | 35914167 | PubTator, text mining | PubMed |
| The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth. | Cancers (Basel) | 2022 | 35884550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/papers?page=21